Efficient Bacterial Genome Engineering throughout the Central Dogma Using the Dual-Selection Marker tetAOPT | ACS Synthetic Biology
Spherical nucleic acids as an infectious disease vaccine platform | PNAS
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers | NEJM
Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case- control study and a mechanistic study of post-vaccination immune responses - The Lancet Infectious
Polymers Strive for Accuracy: From Sequence-Defined Polymers to mRNA Vaccines against COVID-19 and Polymers in Nucleic Acid Therapeutics | Journal of the American Chemical Society
Vaccines | Free Full-Text | A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine
Frontiers | Novel Vaccine Technologies in Veterinary Medicine: A Herald to Human Medicine Vaccines
Next-generation T cell–activating vaccination increases influenza virus mutation prevalence | Science Advances
A Covid-19 Milestone Attained — A Correlate of Protection for Vaccines | NEJM
Vaccination and immunotherapies in neuroimmunological diseases | Nature Reviews Neurology
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis: Trends in Molecular Medicine
COVID-19 vaccine development: milestones, lessons and prospects | Signal Transduction and Targeted Therapy
Peptides for Vaccine Development | ACS Applied Bio Materials
Prevention of host-to-host transmission by SARS-CoV-2 vaccines - The Lancet Infectious Diseases
Enhancing genetic disease control by selecting for lower host infectivity and susceptibility | Heredity
MMWR COVID-19 Reports | MMWR
Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease - ScienceDirect
Live attenuated vaccines, a favorable strategy to provide long-term immunity against protozoan diseases: Trends in Parasitology
Host genetics and infectious disease: new tools, insights and translational opportunities | Nature Reviews Genetics
Eliminated vs. Eradicated: Erasing disease from history — Atlantic Health Partners
Frontiers | SARS-CoV-2 Variants, Vaccines, and Host Immunity
Prospects for a safe COVID-19 vaccine | Science Translational Medicine
Biomaterial vaccines capturing pathogen-associated molecular patterns protect against bacterial infections and septic shock | Nature Biomedical Engineering
Lower probability and shorter duration of infections after COVID-19 vaccine correlate with anti-SARS-CoV-2 circulating IgGs | PLOS ONE
A mass spectrometry guided approach for the identification of novel vaccine candidates in gram-negative pathogens | Scientific Reports
